SlideShare a Scribd company logo
Monday,
February 17,
2014

Case presentation on
ALCOHOLIC LIVER DISEASE
with PORTAL HYPERTENSION
Presented by : ABHIMANYU
PHARM.D
1

PARASHAR
2

 IP

no. : 220024

 UNIT

: medicine 1

 AGE

: 50 yrs

 SEX

: male

 WEIGHT

: 63 Kgs

Monday, February
17, 2014
3

Monday, February 17,
2014

Reasons for admission :
c/o :
 swelling of legs x 1 month (PEDAL EDEMA)
 Distention of abdomen x 1 month
(ASCITIS)
 constipation x 1 month
4

Monday, February 17,
2014

PMHx :
 Admitted

for similar complaints 5 months

back
 Was asymptomatic for 4 months
 k/c/o hypertension x 6 months was on
tab. Meto-ER (metprolol ) 50 mg
 Has been diagnosed with GERD and
GASTRITIS on 8/02/2012
5

Monday, February 17,
2014

SHx :
 Chronic

alcoholic x 15 yrs.
 Smoker x 15 yrs. Left 1 year back
 No Hx of hematuria , yellow discoloration ,
malena and fever
6

Allergies :
 NIL

KNOWN ALLERGIES

Monday, February 17,
2014
7

FHx :
 Not

significant

Monday, February 17,
2014
8

 DIET

: mixed

 APPETITE
 SLEEP

: good

: good

 BOWEL

and BLADDER : normal

Monday, February 17,
2014
9

Monday, February 17,
2014

PROVISIONAL DIAGNOSIS
 Liver

cirrhosis with decompensation with
portal hypertension and essential
hypertension
10

Monday, February 17,
2014

Decompensated cirrhosis ?
 In

patients with previously stable cirrhosis,
decompensation may occur due to
various causes, such as
 constipation
 infection (of any source)
 increased alcohol intake
 medications
 bleeding from esophageal varices
 dehydration.
11












Monday, February 17,
2014

Patients with decompensated cirrhosis
generally require admission to hospital, with
close monitoring of the fluid balance, mental
status,
emphasis on adequate nutrition and medical
treatment - often with
Diuretics
Antibiotics
laxatives
thiamine
occasionally steroids
Administration of saline is generally avoided.
12

DAY NOTES :

Monday, February 17,
2014
13

Monday, February 17,
2014

DAY 1(13/7/2012)
 BP

: 140 / 90 mmHg
 PULSE : 78 BPM
 O/E : CNS – conscious oriented
PALLOR – present
B/L pedal edema
no icterus
CVS : s1s2 heard
R/S : B/L NVBS present
PA : distended , dilated veins
skin : shiny
umbilicus's : everted
14

 Scrotal

 ADV

Monday, February 17,
2014

swelling : present

: tapping 1000 ml (paracenteses)

Start tab FUROSEMIDE + SIPRANOLACTONE
U/C , S/E , ECG , no flaps
15

Monday, February 17,
2014

Ascitis with everted umbilicus and dilated veins
16

LAB REPORTS :

Monday, February 17,
2014
Monday, February 17,
2014

17

Hematology

Biochemistry

Hb : 8.8 g %

RBS : 82 mg/dL

WBC : 8400 cells

UREA : 80 mg/dl

DLC :
N : 69 E : 5
L : 25 M : 1
B:0
PLT : 2.97 LAKHS
ESR : 129 mm/Hr

Electrolytes

Urine
analysis

Na : 140
mmol/l

PUS CELLS :
3

SeCr : 1.1 mg/dl

Cl : 114
mmol/l

SUGAR : 2 %

AST : 38 IU

K : 3.9 mmol/l

ALT : 28 IU

ALP : 250 IU (37-320)
BILLIRUBIN :
T : 0.66 mg/dl
D (BC) : 0.42 mg/dl

RBC : 2-3
cells
ALBUMIN :
+++
18

 IMP

Monday, February 17,
2014

: normocytic normochromic anemia.

 PT/INR

: 1.12
 PCV : 27.9% (42-52)
 Total protein : 5 g/dl ( 6-8 )
 Albumin : 3 g/dl (3.4-5.0)
 A/G ratio : 1.5 ( 1.2 – 2.3 )
19

TREATMENT CHART :

Monday, February
17, 2014
20

50/20
mg

furosemide

/

50/20
mg

Monday, February 17,
2014
21

DAY 2 (14/7/2012)
 BP

: 130/90 mm Hg
 PULSE : 70 BPM
 O/E
CVS : s1s2 heard
CNS : conscious oriented
RS : B/L NVBS present
PA : distended with dilated veins

Monday, February 17,
2014
22

 ADV

: PT/INR , paracenteses ,

 collect

ascitic fluid

Monday, February 17,
2014
23

Monday, February
17, 2014

Ascitic fluid report (14/7/2012)
 12

ml milky fluid
 Cell count : 310
 Cell types : predominantly lymphocytes ,
neutrophils – 15 %
 Glucose : 121 mg/dl ( 40-70 )
 Protein : 10 mg/dl ( 20-45 )
 Chloride : 115 mg/dl ( 116-122)
 LDH : 75 U/L ( 230 – 460 )
24

Monday, February 17,
2014

DAY 3 (15/7/2012)
 BP

: 120 / 80 mm Hg
 PULSE : 70
 O/E : P/A – distended with dilated veins
 Skin – shiny
 Umbilicus - everted
 Abdomen – tensed
 Girth – 96 cm
 ADV – peritoneal biopsy and CST
25

Monday, February 17,
2014

Ascitic fluid culture report
(15/7/2012)
 Gram

 AFB

stain : no cells , no bacteria

not seen
26

Monday, February 17,
2014

DAY 4 (16/7/2012)
 BP

: 130 / 100 mm Hg
 PULSE : 80 BPM
 O/E : c/o weakness in proximal muscles
 CVS - s1s2 heard
 CNS – Pt. conscious oriented
 RS – B/L NVBS present
 P/A – distended with dilated veins
 ADV - CST
27

Monday, February 17,
2014

DAY 5 (17/7/2012)
 BP

: 120 / 90 mm Hg
 PULSE : 82 BPM
 O/E : conscious oriented
 c/o decreased urine output and
constipation with generalized weakness
 P/A –distended , free fluid distended
 ADV - CST
28

Monday, February 17,
2014

DAY 6 (18/7/2012)
 BP

: 128 /80 mm Hg
 PULSE : 82 BPM
 O/E : conscious oriented
 c/o decreased urine output and
constipation with generalized weakness
 P/A –distended , free fluid distended
 ADV - CST
29

Monday, February 17,
2014

DAY 7 (19/7/2012)
 BP

: 130 / 80 mm Hg
 PULSE : 90 BPM
 O/E : conscious oriented
 c/o scrotal swelling and mild fever.
 ADV ascitic tapping
30

Monday, February 17,
2014

DAY 8 (20/7/2012)
 BP

: 128 / 78 mm Hg
 PULSE : 88 BPM
 O/E : conscious oriented
 CVS : s1s2 heard
 RS : B/L NVBS present
 Patient was discharged on request
31

Monday, February 17,
2014

PHARMACEUTICAL CARE
PLAN (SOAP)
32

Monday, February 17,
2014

SUBJECTIVE EVIDENCE
 Swelling

of legs x 1 month
 Distention of abdomen
 others
 K/C/O liver cirrhosis with portal
hypertension and essential hypertension
 SHx : alcoholic x 15 yrs
33

Monday, February
17, 2014

OBJECTIVE EVIDENCE
 Hb

: 8.8 g/dl
 ESR : 120 mm/Hr
 Urea : 80 mg/dl
 Decreased total protein and albumin
 Elevated bilirubin 0.42 mg/dl ( 0 – 0.2 )
34

Monday, February 17,
2014

FINAL DIAGNOSIS
 Based

on subjective and objective
evidence the patients was diagnosed as
ALCOHOLIC LIVER DISEASE with PORTAL
HYPERTENSION and ESSENTIAL
HYPERTENSION
35

Monday, February 17,
2014

cirrhosis
 Cirrhosis

is a consequence of chronic liver
disease characterized by replacement of
liver tissue by fibrosis , scar tissue and
regenerative nodules (lumps that occur
as a result of a process in which
damaged tissue is regenerated),leading
to loss of liver function
36

 In

Monday, February
17, 2014

alcoholic cirrhosis, the nodules are
usually <3 mm in diameter; this form of
cirrhosis is referred to as micronodular
37

Monday, February 17,
2014

Risk Factor

Comment

Quantity

In men, 40–80 g/d of ethanol produces
fatty liver
160 g/d for 10–20 years causes hepatitis or
cirrhosis.
Only 15% of alcoholics develop alcoholic
liver disease

Gender

Women exhibit increased susceptibility to
alcoholic liver disease at amounts >20 g/d;
two drinks per day probably safe.
38

Monday, February 17,
2014

Diagnostic criteria
 Signs

and symptoms
 Asymptomatic
 Hepatomegaly, splenomegaly
 Pruritus, jaundice, palmar erythema, spider
angiomata, hyperpigmentation
 Gynecomastia, reduced libido
 Ascites, edema, pleural effusion, and
respiratory difficulties
 Malaise, anorexia, and weight
 Encephalopathy
39

 Laboratory

Monday, February 17,
2014

tests
 Hypoalbuminemia
 Elevated prothrombin time
 Thrombocytopenia
 Elevated alkaline phosphatase
 Elevated aspartate transaminase (AST),
 alanine transaminase (ALT)
 γ-glutamyl transpeptidase (GGT)
 Elevated billirubin
40

Monday, February
17, 2014
Monday, February 17,
2014

41

Child-Pugh Classification
Score

1

2

3

Bilirubin (mg/dL)

1–2

2–3

>3

Albumin (mg/dL)

>3.5

2.8–3.5

<2.8

Ascites

None

Mild

Moderate

Encephalopathy
(grade)

None

1 and 2

3 and 4

1–4

4–6

>6

Prothrombin
time (seconds
prolonged)

Grade A, < 7 points; grade B, 7–9 points; grade C, 10–15 points.
42

Monday, February 17,
2014

MAYO ESLD (MELD)
 MELD

score =

0.957 × Loge(creatinine mg/dL) + 0.378
× Loge(bilirubin mg/dL) +1.120 × Loge(INR) +
0.643

43

 MELD

Monday, February 17,
2014

score calculation takes into
account a patient’s :
 serum creatinine, bilirubin, international
normalized ratio (INR),
 etiology of liver disease,
 omitting the more subjective reports of
ascites and encephalopathy used in the
Child-Pugh system.
44

Monday, February 17,
2014

GOALS OF TREATMENT
 Assess

the risk for variceal bleeding and
begin pharmacologic prophylaxis where
indicated, reserving endoscopic therapy
for high-risk patients or acute bleeding
episodes
 The patient should be evaluated for
clinical signs of ascites and managed
with pharmacologic treatment (e.g.,
diuretics) and paracenteses.
45

 Prevention

Monday, February 17,
2014

of complications, achieving
adequate lowering of portal pressure with
medical therapy using beta-adrenergic
blocker therapy, or supporting abstinence
from alcohol.
 Careful monitoring for spontaneous
bacterial peritonitis should be employed
in patients with ascites who undergo
acute deterioration
 Frequent monitoring for signs of hepatorenal syndrome, pulmonary insufficiency,
and endocrine dysfunction is necessary
46

 Hepatic

Monday, February 17,
2014

encephalopathy is a common
complication of cirrhosis and requires
clinical vigilance and treatment with
dietary restriction, elimination of central
nervous system depressants, and therapy
to lower ammonia levels
 prevent symptoms and maintain
reasonable QOL
 To provide adequate nutritional support
47

Monday, February 17,
2014

TREATMENT OPTIONS
 Patient

specific :
 for portal hypertension
Propranalol
nadolol
 for

Ascites:
aldosterone antagonists (spiranolactone)
loop diuretics
48

ADJUVENT THERAPY
 Ursodeoxycholic

acid
 Multivitamin supplements
 pantoprazole

Monday, February 17,
2014
49

Monday, February 17,
2014

GOALS ACHIEVED
 Paracenteses

was started on day 1(1000
ml fluid was removed ) and patient was
feeling relived from his abdominal
distention
 Patient was feeling better by day 8 and
was discharged on request.
50

Monday, February 17,
2014

PROBLEMS IDENTIFIED
 Untreated

indication : ANEMIA
 PT/INR was not repeated
 Patient was not started on antibiotics as a
prophylaxis for spontaneous bacterial
peritonitis
 Patient was not started on syrup lactulose
even though patient was on high risk to
develop encephalopathy
51

Monday, February 17,
2014

MONITORING PARAMETERS
 Liver

function test
 BLOOD SUGAR
 Blood Pressure
 Electrolytes (Na and K)
 body weight
 prothrombin time
 Complete hemogram
 USG Abdomen
52

Monday, February 17,
2014

PATIENT COUNSELLING
53

About the disease


Non curable disease.



Risk factor



Signs and symptoms

Monday, February 17,
2014
54

About medication


Name and purpose



Dose and frequency



Medication adherence



Possible adverse effects



Missed dose

Monday, February
17, 2014
55

Monday, February 17,
2014

About life style modification
Stop taking alcohol
Smoking cessation
Nutritious diet
Monday,
February 17,
2014

QUIT BEFORE ITS
LATE

THANK
YOU
56

More Related Content

What's hot

Case presentation on Alcoholic liver disease
Case presentation on Alcoholic liver diseaseCase presentation on Alcoholic liver disease
Case presentation on Alcoholic liver disease
HAMMADKC
 
A case study on Pangastritis with pancreatitis
A case study on Pangastritis with pancreatitis A case study on Pangastritis with pancreatitis
A case study on Pangastritis with pancreatitis
martinshaji
 
A case study on acute renal failure
A case study on acute renal failureA case study on acute renal failure
A case study on acute renal failure
DrMaheshGurajapu
 
case on deep vein thrombosis
case on deep vein thrombosis case on deep vein thrombosis
case on deep vein thrombosis
maheshwari14
 
PARKINSON CASE FINAL
PARKINSON CASE FINALPARKINSON CASE FINAL
PARKINSON CASE FINAL
Kanmani Srinivasan
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
Vigneswari Paladugu
 
Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...
Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...
Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...
Riya Mariam
 
A case study on uti
A case study on utiA case study on uti
A case study on uti
DrMaheshGurajapu
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
Satya satyanittu4
 
Severe alcoholic hepatitis
Severe alcoholic hepatitisSevere alcoholic hepatitis
Severe alcoholic hepatitis
Anusha Rameshwaram
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
DrMaheshGurajapu
 
viral hepatitis
viral hepatitis viral hepatitis
viral hepatitis
Pooja Panjwani
 
Case presentation on MYOCARDIAL INFARCTION
Case presentation on MYOCARDIAL INFARCTIONCase presentation on MYOCARDIAL INFARCTION
Case presentation on MYOCARDIAL INFARCTION
Vigneswari Paladugu
 
5. a case study on rheumatoid arthritis
5. a case study on rheumatoid arthritis5. a case study on rheumatoid arthritis
5. a case study on rheumatoid arthritis
Dr. Ajita Sadhukhan
 
CASE PRESENTATION ON RHEUMATOID ARTHRITIS
CASE PRESENTATION ON RHEUMATOID ARTHRITISCASE PRESENTATION ON RHEUMATOID ARTHRITIS
CASE PRESENTATION ON RHEUMATOID ARTHRITIS
Binuja S.S
 
COPD presentation
COPD presentationCOPD presentation
COPD presentation
Kathy Chow
 
cerebrovascular accident
 cerebrovascular accident cerebrovascular accident
cerebrovascular accident
Rumana Hameed
 
A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)
A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)
A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)
Dr.Hashim Syed Ali (Dr.Foster)
 
Case Presentation on STROKE (Subarachnoid Hemorrhage)
Case Presentation on STROKE (Subarachnoid Hemorrhage)Case Presentation on STROKE (Subarachnoid Hemorrhage)
Case Presentation on STROKE (Subarachnoid Hemorrhage)
nayanadiv
 
Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...
Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...
Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...
Dr Arpan Dutta Roy
 

What's hot (20)

Case presentation on Alcoholic liver disease
Case presentation on Alcoholic liver diseaseCase presentation on Alcoholic liver disease
Case presentation on Alcoholic liver disease
 
A case study on Pangastritis with pancreatitis
A case study on Pangastritis with pancreatitis A case study on Pangastritis with pancreatitis
A case study on Pangastritis with pancreatitis
 
A case study on acute renal failure
A case study on acute renal failureA case study on acute renal failure
A case study on acute renal failure
 
case on deep vein thrombosis
case on deep vein thrombosis case on deep vein thrombosis
case on deep vein thrombosis
 
PARKINSON CASE FINAL
PARKINSON CASE FINALPARKINSON CASE FINAL
PARKINSON CASE FINAL
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
 
Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...
Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...
Case Presentation On Thrombocytopenia with Acute Renal Failure And Acute Depr...
 
A case study on uti
A case study on utiA case study on uti
A case study on uti
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
 
Severe alcoholic hepatitis
Severe alcoholic hepatitisSevere alcoholic hepatitis
Severe alcoholic hepatitis
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
 
viral hepatitis
viral hepatitis viral hepatitis
viral hepatitis
 
Case presentation on MYOCARDIAL INFARCTION
Case presentation on MYOCARDIAL INFARCTIONCase presentation on MYOCARDIAL INFARCTION
Case presentation on MYOCARDIAL INFARCTION
 
5. a case study on rheumatoid arthritis
5. a case study on rheumatoid arthritis5. a case study on rheumatoid arthritis
5. a case study on rheumatoid arthritis
 
CASE PRESENTATION ON RHEUMATOID ARTHRITIS
CASE PRESENTATION ON RHEUMATOID ARTHRITISCASE PRESENTATION ON RHEUMATOID ARTHRITIS
CASE PRESENTATION ON RHEUMATOID ARTHRITIS
 
COPD presentation
COPD presentationCOPD presentation
COPD presentation
 
cerebrovascular accident
 cerebrovascular accident cerebrovascular accident
cerebrovascular accident
 
A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)
A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)
A CASE PRESENTATION ON IBD (INFLAMMATORY BOWEL DISEASE)
 
Case Presentation on STROKE (Subarachnoid Hemorrhage)
Case Presentation on STROKE (Subarachnoid Hemorrhage)Case Presentation on STROKE (Subarachnoid Hemorrhage)
Case Presentation on STROKE (Subarachnoid Hemorrhage)
 
Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...
Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...
Case Presentation on Parkinsons (Clinical Pharmacy practice) By Dr Ruth, Dr A...
 

Viewers also liked

Liver 2
Liver 2Liver 2
A case of recurrent vomiting
A case of recurrent vomitingA case of recurrent vomiting
A case of recurrent vomiting
Atit Ghoda
 
Neuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussionNeuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussion
Pratyush Chaudhuri
 
Gallstones
GallstonesGallstones
Gallstones
camiij1
 
Alcoholic Liver Disease
Alcoholic Liver DiseaseAlcoholic Liver Disease
Alcoholic Liver Disease
arpita khasnavis
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
Shaikhani.
 
CHEMOTHERAPY PREPARATION AND STABILITY CHART
CHEMOTHERAPY PREPARATION AND STABILITY CHARTCHEMOTHERAPY PREPARATION AND STABILITY CHART
CHEMOTHERAPY PREPARATION AND STABILITY CHART
Clinica de imagenes
 
Liver failure in an infant dr. vikrant sood
Liver failure in an infant    dr. vikrant soodLiver failure in an infant    dr. vikrant sood
Liver failure in an infant dr. vikrant sood
Sanjeev Kumar
 
Alcoholic liver cirrhosis
Alcoholic liver cirrhosisAlcoholic liver cirrhosis
Alcoholic liver cirrhosis
surya720
 
Case study
Case study Case study
Case study
Pooja Panjwani
 
Alcoholiclivercirrhosis
AlcoholiclivercirrhosisAlcoholiclivercirrhosis
Alcoholiclivercirrhosis
velspharmd
 
Epilepsy case study presentation
Epilepsy case study presentationEpilepsy case study presentation
Epilepsy case study presentation
Amy00Good
 
Wilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentationWilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentation
Sanjeev Kumar
 
A case study on cirrhosis of liver
A case study on cirrhosis of liverA case study on cirrhosis of liver
A case study on cirrhosis of liver
education4227
 
Acute Liver Failure
Acute Liver FailureAcute Liver Failure
Acute Liver Failure
David Anderson
 
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
MD Specialclass
 
Cystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study PresentationCystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study Presentation
Mary Rodavich
 
Liver Cirrhosis
Liver CirrhosisLiver Cirrhosis
Liver Cirrhosis
Jack Frost
 
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
Arlyn Valencia, M.D.
 
Bradycardia Assessment and Management
Bradycardia Assessment and ManagementBradycardia Assessment and Management
Bradycardia Assessment and Management
SCGH ED CME
 

Viewers also liked (20)

Liver 2
Liver 2Liver 2
Liver 2
 
A case of recurrent vomiting
A case of recurrent vomitingA case of recurrent vomiting
A case of recurrent vomiting
 
Neuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussionNeuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussion
 
Gallstones
GallstonesGallstones
Gallstones
 
Alcoholic Liver Disease
Alcoholic Liver DiseaseAlcoholic Liver Disease
Alcoholic Liver Disease
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
 
CHEMOTHERAPY PREPARATION AND STABILITY CHART
CHEMOTHERAPY PREPARATION AND STABILITY CHARTCHEMOTHERAPY PREPARATION AND STABILITY CHART
CHEMOTHERAPY PREPARATION AND STABILITY CHART
 
Liver failure in an infant dr. vikrant sood
Liver failure in an infant    dr. vikrant soodLiver failure in an infant    dr. vikrant sood
Liver failure in an infant dr. vikrant sood
 
Alcoholic liver cirrhosis
Alcoholic liver cirrhosisAlcoholic liver cirrhosis
Alcoholic liver cirrhosis
 
Case study
Case study Case study
Case study
 
Alcoholiclivercirrhosis
AlcoholiclivercirrhosisAlcoholiclivercirrhosis
Alcoholiclivercirrhosis
 
Epilepsy case study presentation
Epilepsy case study presentationEpilepsy case study presentation
Epilepsy case study presentation
 
Wilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentationWilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentation
 
A case study on cirrhosis of liver
A case study on cirrhosis of liverA case study on cirrhosis of liver
A case study on cirrhosis of liver
 
Acute Liver Failure
Acute Liver FailureAcute Liver Failure
Acute Liver Failure
 
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Cystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study PresentationCystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study Presentation
 
Liver Cirrhosis
Liver CirrhosisLiver Cirrhosis
Liver Cirrhosis
 
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
 
Bradycardia Assessment and Management
Bradycardia Assessment and ManagementBradycardia Assessment and Management
Bradycardia Assessment and Management
 

Similar to ALD with portal htn

LVF with HTN and T2DM and PD
LVF with HTN and T2DM and PDLVF with HTN and T2DM and PD
LVF with HTN and T2DM and PD
Dr. Abhimanyu Prashar
 
CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...
CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...
CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...
Soroy Lardo
 
11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease
Dr. Ajita Sadhukhan
 
ACLF mortality1.pptx
ACLF mortality1.pptxACLF mortality1.pptx
ACLF mortality1.pptx
Ravi Ravi
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
glyf26shai
 
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
Bng Crz
 
Management of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptxManagement of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptx
Ernest Osemudiamen Salami
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
NitariRahmi
 
Atypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeAtypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndrome
Dr Shami Bhagat
 
Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)
Joan Ng
 
Acute on chronic hepatitis b
Acute on chronic hepatitis bAcute on chronic hepatitis b
Acute on chronic hepatitis b
Dondy Juliansyah
 
Admitted Case of Vasculitis in National Institute of Child Health
Admitted Case of  Vasculitis in National Institute of Child HealthAdmitted Case of  Vasculitis in National Institute of Child Health
Admitted Case of Vasculitis in National Institute of Child Health
DrMSajidNoor
 
A Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein PurpuraA Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein Purpura
Stanley Medical College, Department of Medicine
 
Case presentation pleural effusion
Case presentation pleural effusionCase presentation pleural effusion
Case presentation pleural effusion
jagadish mishra
 
Interesting Case of Rowells syndrome
Interesting Case of Rowells syndromeInteresting Case of Rowells syndrome
Interesting Case of Rowells syndrome
Ramaiah Medical College
 
Chronic Liver Disease(pediatrics)
Chronic Liver Disease(pediatrics)Chronic Liver Disease(pediatrics)
Chronic Liver Disease(pediatrics)
Manoj Ghoda
 
Case pancretitis
Case pancretitisCase pancretitis
Case pancretitis
Kamal Mergani
 
MORTALITY MEET
MORTALITY MEETMORTALITY MEET
MORTALITY MEET
Dr. Prem Mohan Jha
 
21. #ifad2019 how to guide deresuscitation (malbrain)
21. #ifad2019 how to guide deresuscitation (malbrain)21. #ifad2019 how to guide deresuscitation (malbrain)
21. #ifad2019 how to guide deresuscitation (malbrain)
International Fluid Academy
 
Clinical Case Study
Clinical Case StudyClinical Case Study
Clinical Case Study
Ashley Hamilton
 

Similar to ALD with portal htn (20)

LVF with HTN and T2DM and PD
LVF with HTN and T2DM and PDLVF with HTN and T2DM and PD
LVF with HTN and T2DM and PD
 
CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...
CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...
CKD AND HHD DUTY REPORT DEPARTMENT OF INTERNAL MEDICINE RSAPAD GATOT SEOBROTO...
 
11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease
 
ACLF mortality1.pptx
ACLF mortality1.pptxACLF mortality1.pptx
ACLF mortality1.pptx
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
 
Management of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptxManagement of Chronic Kidney Disease.pptx
Management of Chronic Kidney Disease.pptx
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
 
Atypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndromeAtypical Hemolytic uremic syndrome
Atypical Hemolytic uremic syndrome
 
Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)
 
Acute on chronic hepatitis b
Acute on chronic hepatitis bAcute on chronic hepatitis b
Acute on chronic hepatitis b
 
Admitted Case of Vasculitis in National Institute of Child Health
Admitted Case of  Vasculitis in National Institute of Child HealthAdmitted Case of  Vasculitis in National Institute of Child Health
Admitted Case of Vasculitis in National Institute of Child Health
 
A Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein PurpuraA Case of Henoch-Schonlein Purpura
A Case of Henoch-Schonlein Purpura
 
Case presentation pleural effusion
Case presentation pleural effusionCase presentation pleural effusion
Case presentation pleural effusion
 
Interesting Case of Rowells syndrome
Interesting Case of Rowells syndromeInteresting Case of Rowells syndrome
Interesting Case of Rowells syndrome
 
Chronic Liver Disease(pediatrics)
Chronic Liver Disease(pediatrics)Chronic Liver Disease(pediatrics)
Chronic Liver Disease(pediatrics)
 
Case pancretitis
Case pancretitisCase pancretitis
Case pancretitis
 
MORTALITY MEET
MORTALITY MEETMORTALITY MEET
MORTALITY MEET
 
21. #ifad2019 how to guide deresuscitation (malbrain)
21. #ifad2019 how to guide deresuscitation (malbrain)21. #ifad2019 how to guide deresuscitation (malbrain)
21. #ifad2019 how to guide deresuscitation (malbrain)
 
Clinical Case Study
Clinical Case StudyClinical Case Study
Clinical Case Study
 

More from Dr. Abhimanyu Prashar

FIRST AID MEASURES IN POISONING
FIRST AID MEASURES IN POISONINGFIRST AID MEASURES IN POISONING
FIRST AID MEASURES IN POISONING
Dr. Abhimanyu Prashar
 
POISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONING
POISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONINGPOISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONING
POISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONING
Dr. Abhimanyu Prashar
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & Responsibilities
Dr. Abhimanyu Prashar
 
Systematic approach to answer Poison Information Query
Systematic approach to answer Poison Information QuerySystematic approach to answer Poison Information Query
Systematic approach to answer Poison Information Query
Dr. Abhimanyu Prashar
 
Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)
Dr. Abhimanyu Prashar
 
Case on Heart failure with Type 2 Diabetes mellitus
Case on Heart failure with Type 2 Diabetes mellitusCase on Heart failure with Type 2 Diabetes mellitus
Case on Heart failure with Type 2 Diabetes mellitus
Dr. Abhimanyu Prashar
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
Dr. Abhimanyu Prashar
 
Respiratory system
Respiratory systemRespiratory system
Respiratory system
Dr. Abhimanyu Prashar
 
Digestive System
Digestive SystemDigestive System
Digestive System
Dr. Abhimanyu Prashar
 
Skeletal system
Skeletal systemSkeletal system
Skeletal system
Dr. Abhimanyu Prashar
 
Lymphatic system
Lymphatic systemLymphatic system
Lymphatic system
Dr. Abhimanyu Prashar
 
Medication errors: Causes, Assessment, Evaluation and Prevention
Medication errors: Causes, Assessment, Evaluation and PreventionMedication errors: Causes, Assessment, Evaluation and Prevention
Medication errors: Causes, Assessment, Evaluation and Prevention
Dr. Abhimanyu Prashar
 
Peptic Ulcer Disease
Peptic Ulcer DiseasePeptic Ulcer Disease
Peptic Ulcer Disease
Dr. Abhimanyu Prashar
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
Dr. Abhimanyu Prashar
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
Dr. Abhimanyu Prashar
 
Gastro Esophageal Reflux Disease
Gastro Esophageal Reflux DiseaseGastro Esophageal Reflux Disease
Gastro Esophageal Reflux Disease
Dr. Abhimanyu Prashar
 
Cell division (Mitosis and Meiosis)
Cell division (Mitosis and Meiosis)Cell division (Mitosis and Meiosis)
Cell division (Mitosis and Meiosis)
Dr. Abhimanyu Prashar
 
Cells and organisation of body
Cells and organisation of bodyCells and organisation of body
Cells and organisation of body
Dr. Abhimanyu Prashar
 
Medication Errors in General Medicine wards of a tertiary care teaching Hospi...
Medication Errors in General Medicine wards of a tertiary care teaching Hospi...Medication Errors in General Medicine wards of a tertiary care teaching Hospi...
Medication Errors in General Medicine wards of a tertiary care teaching Hospi...
Dr. Abhimanyu Prashar
 
Venous ulcer
Venous ulcerVenous ulcer
Venous ulcer
Dr. Abhimanyu Prashar
 

More from Dr. Abhimanyu Prashar (20)

FIRST AID MEASURES IN POISONING
FIRST AID MEASURES IN POISONINGFIRST AID MEASURES IN POISONING
FIRST AID MEASURES IN POISONING
 
POISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONING
POISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONINGPOISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONING
POISON INFORMATION CENTER AWARENESS & FIRST AID MEASURES FOR POISONING
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & Responsibilities
 
Systematic approach to answer Poison Information Query
Systematic approach to answer Poison Information QuerySystematic approach to answer Poison Information Query
Systematic approach to answer Poison Information Query
 
Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)
 
Case on Heart failure with Type 2 Diabetes mellitus
Case on Heart failure with Type 2 Diabetes mellitusCase on Heart failure with Type 2 Diabetes mellitus
Case on Heart failure with Type 2 Diabetes mellitus
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
Respiratory system
Respiratory systemRespiratory system
Respiratory system
 
Digestive System
Digestive SystemDigestive System
Digestive System
 
Skeletal system
Skeletal systemSkeletal system
Skeletal system
 
Lymphatic system
Lymphatic systemLymphatic system
Lymphatic system
 
Medication errors: Causes, Assessment, Evaluation and Prevention
Medication errors: Causes, Assessment, Evaluation and PreventionMedication errors: Causes, Assessment, Evaluation and Prevention
Medication errors: Causes, Assessment, Evaluation and Prevention
 
Peptic Ulcer Disease
Peptic Ulcer DiseasePeptic Ulcer Disease
Peptic Ulcer Disease
 
Ischemic Heart Disease
Ischemic Heart DiseaseIschemic Heart Disease
Ischemic Heart Disease
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
 
Gastro Esophageal Reflux Disease
Gastro Esophageal Reflux DiseaseGastro Esophageal Reflux Disease
Gastro Esophageal Reflux Disease
 
Cell division (Mitosis and Meiosis)
Cell division (Mitosis and Meiosis)Cell division (Mitosis and Meiosis)
Cell division (Mitosis and Meiosis)
 
Cells and organisation of body
Cells and organisation of bodyCells and organisation of body
Cells and organisation of body
 
Medication Errors in General Medicine wards of a tertiary care teaching Hospi...
Medication Errors in General Medicine wards of a tertiary care teaching Hospi...Medication Errors in General Medicine wards of a tertiary care teaching Hospi...
Medication Errors in General Medicine wards of a tertiary care teaching Hospi...
 
Venous ulcer
Venous ulcerVenous ulcer
Venous ulcer
 

Recently uploaded

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 

ALD with portal htn

  • 1. Monday, February 17, 2014 Case presentation on ALCOHOLIC LIVER DISEASE with PORTAL HYPERTENSION Presented by : ABHIMANYU PHARM.D 1 PARASHAR
  • 2. 2  IP no. : 220024  UNIT : medicine 1  AGE : 50 yrs  SEX : male  WEIGHT : 63 Kgs Monday, February 17, 2014
  • 3. 3 Monday, February 17, 2014 Reasons for admission : c/o :  swelling of legs x 1 month (PEDAL EDEMA)  Distention of abdomen x 1 month (ASCITIS)  constipation x 1 month
  • 4. 4 Monday, February 17, 2014 PMHx :  Admitted for similar complaints 5 months back  Was asymptomatic for 4 months  k/c/o hypertension x 6 months was on tab. Meto-ER (metprolol ) 50 mg  Has been diagnosed with GERD and GASTRITIS on 8/02/2012
  • 5. 5 Monday, February 17, 2014 SHx :  Chronic alcoholic x 15 yrs.  Smoker x 15 yrs. Left 1 year back  No Hx of hematuria , yellow discoloration , malena and fever
  • 6. 6 Allergies :  NIL KNOWN ALLERGIES Monday, February 17, 2014
  • 8. 8  DIET : mixed  APPETITE  SLEEP : good : good  BOWEL and BLADDER : normal Monday, February 17, 2014
  • 9. 9 Monday, February 17, 2014 PROVISIONAL DIAGNOSIS  Liver cirrhosis with decompensation with portal hypertension and essential hypertension
  • 10. 10 Monday, February 17, 2014 Decompensated cirrhosis ?  In patients with previously stable cirrhosis, decompensation may occur due to various causes, such as  constipation  infection (of any source)  increased alcohol intake  medications  bleeding from esophageal varices  dehydration.
  • 11. 11         Monday, February 17, 2014 Patients with decompensated cirrhosis generally require admission to hospital, with close monitoring of the fluid balance, mental status, emphasis on adequate nutrition and medical treatment - often with Diuretics Antibiotics laxatives thiamine occasionally steroids Administration of saline is generally avoided.
  • 12. 12 DAY NOTES : Monday, February 17, 2014
  • 13. 13 Monday, February 17, 2014 DAY 1(13/7/2012)  BP : 140 / 90 mmHg  PULSE : 78 BPM  O/E : CNS – conscious oriented PALLOR – present B/L pedal edema no icterus CVS : s1s2 heard R/S : B/L NVBS present PA : distended , dilated veins skin : shiny umbilicus's : everted
  • 14. 14  Scrotal  ADV Monday, February 17, 2014 swelling : present : tapping 1000 ml (paracenteses) Start tab FUROSEMIDE + SIPRANOLACTONE U/C , S/E , ECG , no flaps
  • 15. 15 Monday, February 17, 2014 Ascitis with everted umbilicus and dilated veins
  • 16. 16 LAB REPORTS : Monday, February 17, 2014
  • 17. Monday, February 17, 2014 17 Hematology Biochemistry Hb : 8.8 g % RBS : 82 mg/dL WBC : 8400 cells UREA : 80 mg/dl DLC : N : 69 E : 5 L : 25 M : 1 B:0 PLT : 2.97 LAKHS ESR : 129 mm/Hr Electrolytes Urine analysis Na : 140 mmol/l PUS CELLS : 3 SeCr : 1.1 mg/dl Cl : 114 mmol/l SUGAR : 2 % AST : 38 IU K : 3.9 mmol/l ALT : 28 IU ALP : 250 IU (37-320) BILLIRUBIN : T : 0.66 mg/dl D (BC) : 0.42 mg/dl RBC : 2-3 cells ALBUMIN : +++
  • 18. 18  IMP Monday, February 17, 2014 : normocytic normochromic anemia.  PT/INR : 1.12  PCV : 27.9% (42-52)  Total protein : 5 g/dl ( 6-8 )  Albumin : 3 g/dl (3.4-5.0)  A/G ratio : 1.5 ( 1.2 – 2.3 )
  • 19. 19 TREATMENT CHART : Monday, February 17, 2014
  • 21. 21 DAY 2 (14/7/2012)  BP : 130/90 mm Hg  PULSE : 70 BPM  O/E CVS : s1s2 heard CNS : conscious oriented RS : B/L NVBS present PA : distended with dilated veins Monday, February 17, 2014
  • 22. 22  ADV : PT/INR , paracenteses ,  collect ascitic fluid Monday, February 17, 2014
  • 23. 23 Monday, February 17, 2014 Ascitic fluid report (14/7/2012)  12 ml milky fluid  Cell count : 310  Cell types : predominantly lymphocytes , neutrophils – 15 %  Glucose : 121 mg/dl ( 40-70 )  Protein : 10 mg/dl ( 20-45 )  Chloride : 115 mg/dl ( 116-122)  LDH : 75 U/L ( 230 – 460 )
  • 24. 24 Monday, February 17, 2014 DAY 3 (15/7/2012)  BP : 120 / 80 mm Hg  PULSE : 70  O/E : P/A – distended with dilated veins  Skin – shiny  Umbilicus - everted  Abdomen – tensed  Girth – 96 cm  ADV – peritoneal biopsy and CST
  • 25. 25 Monday, February 17, 2014 Ascitic fluid culture report (15/7/2012)  Gram  AFB stain : no cells , no bacteria not seen
  • 26. 26 Monday, February 17, 2014 DAY 4 (16/7/2012)  BP : 130 / 100 mm Hg  PULSE : 80 BPM  O/E : c/o weakness in proximal muscles  CVS - s1s2 heard  CNS – Pt. conscious oriented  RS – B/L NVBS present  P/A – distended with dilated veins  ADV - CST
  • 27. 27 Monday, February 17, 2014 DAY 5 (17/7/2012)  BP : 120 / 90 mm Hg  PULSE : 82 BPM  O/E : conscious oriented  c/o decreased urine output and constipation with generalized weakness  P/A –distended , free fluid distended  ADV - CST
  • 28. 28 Monday, February 17, 2014 DAY 6 (18/7/2012)  BP : 128 /80 mm Hg  PULSE : 82 BPM  O/E : conscious oriented  c/o decreased urine output and constipation with generalized weakness  P/A –distended , free fluid distended  ADV - CST
  • 29. 29 Monday, February 17, 2014 DAY 7 (19/7/2012)  BP : 130 / 80 mm Hg  PULSE : 90 BPM  O/E : conscious oriented  c/o scrotal swelling and mild fever.  ADV ascitic tapping
  • 30. 30 Monday, February 17, 2014 DAY 8 (20/7/2012)  BP : 128 / 78 mm Hg  PULSE : 88 BPM  O/E : conscious oriented  CVS : s1s2 heard  RS : B/L NVBS present  Patient was discharged on request
  • 32. 32 Monday, February 17, 2014 SUBJECTIVE EVIDENCE  Swelling of legs x 1 month  Distention of abdomen  others  K/C/O liver cirrhosis with portal hypertension and essential hypertension  SHx : alcoholic x 15 yrs
  • 33. 33 Monday, February 17, 2014 OBJECTIVE EVIDENCE  Hb : 8.8 g/dl  ESR : 120 mm/Hr  Urea : 80 mg/dl  Decreased total protein and albumin  Elevated bilirubin 0.42 mg/dl ( 0 – 0.2 )
  • 34. 34 Monday, February 17, 2014 FINAL DIAGNOSIS  Based on subjective and objective evidence the patients was diagnosed as ALCOHOLIC LIVER DISEASE with PORTAL HYPERTENSION and ESSENTIAL HYPERTENSION
  • 35. 35 Monday, February 17, 2014 cirrhosis  Cirrhosis is a consequence of chronic liver disease characterized by replacement of liver tissue by fibrosis , scar tissue and regenerative nodules (lumps that occur as a result of a process in which damaged tissue is regenerated),leading to loss of liver function
  • 36. 36  In Monday, February 17, 2014 alcoholic cirrhosis, the nodules are usually <3 mm in diameter; this form of cirrhosis is referred to as micronodular
  • 37. 37 Monday, February 17, 2014 Risk Factor Comment Quantity In men, 40–80 g/d of ethanol produces fatty liver 160 g/d for 10–20 years causes hepatitis or cirrhosis. Only 15% of alcoholics develop alcoholic liver disease Gender Women exhibit increased susceptibility to alcoholic liver disease at amounts >20 g/d; two drinks per day probably safe.
  • 38. 38 Monday, February 17, 2014 Diagnostic criteria  Signs and symptoms  Asymptomatic  Hepatomegaly, splenomegaly  Pruritus, jaundice, palmar erythema, spider angiomata, hyperpigmentation  Gynecomastia, reduced libido  Ascites, edema, pleural effusion, and respiratory difficulties  Malaise, anorexia, and weight  Encephalopathy
  • 39. 39  Laboratory Monday, February 17, 2014 tests  Hypoalbuminemia  Elevated prothrombin time  Thrombocytopenia  Elevated alkaline phosphatase  Elevated aspartate transaminase (AST),  alanine transaminase (ALT)  γ-glutamyl transpeptidase (GGT)  Elevated billirubin
  • 41. Monday, February 17, 2014 41 Child-Pugh Classification Score 1 2 3 Bilirubin (mg/dL) 1–2 2–3 >3 Albumin (mg/dL) >3.5 2.8–3.5 <2.8 Ascites None Mild Moderate Encephalopathy (grade) None 1 and 2 3 and 4 1–4 4–6 >6 Prothrombin time (seconds prolonged) Grade A, < 7 points; grade B, 7–9 points; grade C, 10–15 points.
  • 42. 42 Monday, February 17, 2014 MAYO ESLD (MELD)  MELD score = 0.957 × Loge(creatinine mg/dL) + 0.378 × Loge(bilirubin mg/dL) +1.120 × Loge(INR) + 0.643 
  • 43. 43  MELD Monday, February 17, 2014 score calculation takes into account a patient’s :  serum creatinine, bilirubin, international normalized ratio (INR),  etiology of liver disease,  omitting the more subjective reports of ascites and encephalopathy used in the Child-Pugh system.
  • 44. 44 Monday, February 17, 2014 GOALS OF TREATMENT  Assess the risk for variceal bleeding and begin pharmacologic prophylaxis where indicated, reserving endoscopic therapy for high-risk patients or acute bleeding episodes  The patient should be evaluated for clinical signs of ascites and managed with pharmacologic treatment (e.g., diuretics) and paracenteses.
  • 45. 45  Prevention Monday, February 17, 2014 of complications, achieving adequate lowering of portal pressure with medical therapy using beta-adrenergic blocker therapy, or supporting abstinence from alcohol.  Careful monitoring for spontaneous bacterial peritonitis should be employed in patients with ascites who undergo acute deterioration  Frequent monitoring for signs of hepatorenal syndrome, pulmonary insufficiency, and endocrine dysfunction is necessary
  • 46. 46  Hepatic Monday, February 17, 2014 encephalopathy is a common complication of cirrhosis and requires clinical vigilance and treatment with dietary restriction, elimination of central nervous system depressants, and therapy to lower ammonia levels  prevent symptoms and maintain reasonable QOL  To provide adequate nutritional support
  • 47. 47 Monday, February 17, 2014 TREATMENT OPTIONS  Patient specific :  for portal hypertension Propranalol nadolol  for Ascites: aldosterone antagonists (spiranolactone) loop diuretics
  • 48. 48 ADJUVENT THERAPY  Ursodeoxycholic acid  Multivitamin supplements  pantoprazole Monday, February 17, 2014
  • 49. 49 Monday, February 17, 2014 GOALS ACHIEVED  Paracenteses was started on day 1(1000 ml fluid was removed ) and patient was feeling relived from his abdominal distention  Patient was feeling better by day 8 and was discharged on request.
  • 50. 50 Monday, February 17, 2014 PROBLEMS IDENTIFIED  Untreated indication : ANEMIA  PT/INR was not repeated  Patient was not started on antibiotics as a prophylaxis for spontaneous bacterial peritonitis  Patient was not started on syrup lactulose even though patient was on high risk to develop encephalopathy
  • 51. 51 Monday, February 17, 2014 MONITORING PARAMETERS  Liver function test  BLOOD SUGAR  Blood Pressure  Electrolytes (Na and K)  body weight  prothrombin time  Complete hemogram  USG Abdomen
  • 53. 53 About the disease  Non curable disease.  Risk factor  Signs and symptoms Monday, February 17, 2014
  • 54. 54 About medication  Name and purpose  Dose and frequency  Medication adherence  Possible adverse effects  Missed dose Monday, February 17, 2014
  • 55. 55 Monday, February 17, 2014 About life style modification Stop taking alcohol Smoking cessation Nutritious diet
  • 56. Monday, February 17, 2014 QUIT BEFORE ITS LATE THANK YOU 56